In this episode titled, Aligning Treatment Goals in IgA Nephropathy: Applying KDIGO’s Dual-Pathway Framework to Clinical ...

The thymus peptide upregulated 1,198 genes tied to energy metabolism, DNA repair, and cell cycle regulation. The Thymus ...

Heart failure management includes the four pillars (quad therapy) in HFrEF and HFpEF, plus advances in heart transplantation and gene editing.

A woman in her 60s with a history of atrial fibrillation, hypertension and dyslipidaemia was admitted to the Intensive Care ...

A 74-year-old man with chronic kidney disease (CKD) and type 2 diabetes presented to our nephrology clinic for follow-up of diabetic kidney disease with a serum creatinine of 180 (reference range 59 ...

Vitamin D3 may be one exception as it is important to prevent and treat osteoporosis for those who are at risk. While I often ...

Learn how to manage an IgA nephropathy flare with this detailed action plan. Understand symptoms and prevention to safeguard ...

Vitamin K2 is being evaluated in helping to reduce heart disease risk, but the evidence isn't strong enough yet to recommend it.

A machine learning model incorporating functional assessments predicts one-year mortality in older patients with HF and improves risk stratification beyond established scores. Functional status at ...

I’m a 68-year-old female who is in good health. I currently take vitamin D3. The only prescription that I’m on is ...

Otsuka has claimed FDA approval for its IgA nephropathy (IgAN) therapy Voyxact, joining an increasingly crowded market and beating rival Vera Therapeutics to the punch. Anti-APRIL antibody Voyxact ...

Objectives To examine how the population composition, practice organisation and geographical context of general practice clinics are associated with unwarranted variation in prescribing patterns ...